search
Back to results

Effect of a Modified Oxygen Mask Associated to Nasal Prongs During a High Flow Oxygenation Method

Primary Purpose

Oxygen Inhalation Therapy

Status
Completed
Phase
Not Applicable
Locations
Belgium
Study Type
Interventional
Intervention
Double trunk mask add above a nasal canulae
Sponsored by
Laboratory of Movement, Condorcet, Tournai, Belgium
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Oxygen Inhalation Therapy focused on measuring oxygen mask, high-flow oxygen therapy, acute respiratory failure

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

Regardless of gender, at least 18 years of age and diagnosed with severe Hypoxia (PaO2/FiO2 < 300 mm Hg), dyspnea with severe rest at stake accessory muscles of respiration, respiratory rate (RR) ≥ 25 CPM, PaCO2 ≤ 45 mmHg, patient with an arterial catheter and without hemodynamic instability, Glasgow Coma Scale ≥ 12/15, written consent. Participants were also required to have a sufficient level of education to understand study procedures and be able to communicate with site personnel.

Exclusion Criteria Patients were excluded if they Hypercapnia (> 45 mm Hg with respiratory acidosis), cardiogenic pulmonary edema, COPD, pulmonary fibrosis, hypoventilation obesity syndrom, arterial pressure < 60 mm Hg or treatment by epinephrine > to 0,1 gamma/kg/minute, deterioration of awareness (Glasgow scale < or = 12), acute confusional state.

Participants were randomized in a 1:1 ratio to receive either (CHFONP) classical High Flow Oxygenation with nasal prongs (20 minutes) or CHFNOP with an adjunctive of a DTM.

-

Sites / Locations

  • epicura Hornu

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

Oxygenation only with nasal canula

Oxygenation with double trunk masknasal canula

Arm Description

intervention: classical oxygenation with nasal canula (High flow)

oxygenationwith DTM above nasal canula

Outcomes

Primary Outcome Measures

Level of blood oxygenation (PaO2) after adjunction of a double trunk mask to a high flow oxygen canulae
The primary endpoint was the change of PaO2. Sequence (Figure 1): The patient should be placed in semi-seated (position at 45 °) Patient will be oxygenated with high-fow nasal cannula (HFNC). Fraction delivered in Oxygen and flow rate will be adjusted to obtain a Saturation in oxygen > at 90%. Arterial gazometry will be taken after 20 and 60 minutes wih HFNC. The clinician will associate the Double Trunk Mask (DTM) with the same parameters of the high-fow nasal cannula. Arterial gazometry will be performed after 20 and 60 minutes after placement of DTM. After the withdrawal of DTM, arterial gazometry will be performed after 20 and 60 minutes

Secondary Outcome Measures

Full Information

First Posted
October 5, 2017
Last Updated
October 24, 2017
Sponsor
Laboratory of Movement, Condorcet, Tournai, Belgium
search

1. Study Identification

Unique Protocol Identification Number
NCT03319602
Brief Title
Effect of a Modified Oxygen Mask Associated to Nasal Prongs During a High Flow Oxygenation Method
Official Title
Effect of a Double Trunk Mask Associated to Nasal Prongs During a High Flow Oxygenation Method
Study Type
Interventional

2. Study Status

Record Verification Date
October 2017
Overall Recruitment Status
Completed
Study Start Date
February 1, 2017 (Actual)
Primary Completion Date
June 1, 2017 (Actual)
Study Completion Date
September 2, 2017 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Laboratory of Movement, Condorcet, Tournai, Belgium

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The aim of this study is to determine the effect (on PaO2) of a modified mask associated to nasal cannula used for high flow oxygenation.
Detailed Description
Study Design This is a single-center, randomized, blind investigator, 2-way crossover study design. Enrolled participants had severe hypoxia being treated at Intensive Care Unit associated with a hospital in Hornu (Epicura). The study consisted of two intervention periods of 2 weeks separated by a washout period of 20 minutes. (Figure 1) The objective of the study is to determine whether adjunctive mask of our design (Double Trunk Mask - DTM) has an effect on increasing arterial pressure in Oxygen (PaO2) diagnosed with severe hypoxia. The protocol and informed consent documents were reviewed and approved by a recognized ethics review board at the study facility. The study was performed in accordance with the Declaration of Helsinki. Statistical Analysis All participants who received this intervention and completed two phases of study were included in the efficacy analysis. A sample size of 15 participants was needed to provide 90% power to detect a 10 mm Hg difference in PaO2. ANOVA for repeated measures followed by a post hoc test were used to compare the difference between participants receiving (CHFONP + DTM) and CHFONP alone. The test was performed with a significance level of 0.05 (two-sided). Statistical analyses were carried out using SigmaPlot software version 11.0 (Systat Software Inc. UK). Adverse Event Assessment Safety was assessed by the number of participants with adverse events (AEs). AEs were collected by systematic assessment using terms from the Medical Dictionary for Regulatory Activities (MedDRA), version 11.1 in participants who received one or more doses of intervention. Adverse events during washout were not collected.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Oxygen Inhalation Therapy
Keywords
oxygen mask, high-flow oxygen therapy, acute respiratory failure

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Model Description
Comparison of level oxygenation between classical oxygenation with nasal canulae with or without adjunctive of a double trunk mask
Masking
Outcomes Assessor
Masking Description
Assessor blind
Allocation
Non-Randomized
Enrollment
15 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Oxygenation only with nasal canula
Arm Type
Active Comparator
Arm Description
intervention: classical oxygenation with nasal canula (High flow)
Arm Title
Oxygenation with double trunk masknasal canula
Arm Type
Experimental
Arm Description
oxygenationwith DTM above nasal canula
Intervention Type
Device
Intervention Name(s)
Double trunk mask add above a nasal canulae
Intervention Description
oxygenation only with nostril prongs
Primary Outcome Measure Information:
Title
Level of blood oxygenation (PaO2) after adjunction of a double trunk mask to a high flow oxygen canulae
Description
The primary endpoint was the change of PaO2. Sequence (Figure 1): The patient should be placed in semi-seated (position at 45 °) Patient will be oxygenated with high-fow nasal cannula (HFNC). Fraction delivered in Oxygen and flow rate will be adjusted to obtain a Saturation in oxygen > at 90%. Arterial gazometry will be taken after 20 and 60 minutes wih HFNC. The clinician will associate the Double Trunk Mask (DTM) with the same parameters of the high-fow nasal cannula. Arterial gazometry will be performed after 20 and 60 minutes after placement of DTM. After the withdrawal of DTM, arterial gazometry will be performed after 20 and 60 minutes
Time Frame
4 hours

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Regardless of gender, at least 18 years of age and diagnosed with severe Hypoxia (PaO2/FiO2 < 300 mm Hg), dyspnea with severe rest at stake accessory muscles of respiration, respiratory rate (RR) ≥ 25 CPM, PaCO2 ≤ 45 mmHg, patient with an arterial catheter and without hemodynamic instability, Glasgow Coma Scale ≥ 12/15, written consent. Participants were also required to have a sufficient level of education to understand study procedures and be able to communicate with site personnel. Exclusion Criteria Patients were excluded if they Hypercapnia (> 45 mm Hg with respiratory acidosis), cardiogenic pulmonary edema, COPD, pulmonary fibrosis, hypoventilation obesity syndrom, arterial pressure < 60 mm Hg or treatment by epinephrine > to 0,1 gamma/kg/minute, deterioration of awareness (Glasgow scale < or = 12), acute confusional state. Participants were randomized in a 1:1 ratio to receive either (CHFONP) classical High Flow Oxygenation with nasal prongs (20 minutes) or CHFNOP with an adjunctive of a DTM. -
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
frédéric mr duprez, Msc
Organizational Affiliation
Condorcet
Official's Role
Principal Investigator
Facility Information:
Facility Name
epicura Hornu
City
Hornu
State/Province
Hainaut
ZIP/Postal Code
7301
Country
Belgium

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
9635651
Citation
Hnatiuk OW, Moores LK, Thompson JC, Jones MD. Delivery of high concentrations of inspired oxygen via Tusk mask. Crit Care Med. 1998 Jun;26(6):1032-5. doi: 10.1097/00003246-199806000-00022.
Results Reference
result
PubMed Identifier
1959399
Citation
Chechani V, Scott G, Burnham B, Knight L. Modification of an aerosol mask to provide high concentrations of oxygen in the inspired air. Comparison to a nonrebreathing mask. Chest. 1991 Dec;100(6):1582-5. doi: 10.1378/chest.100.6.1582.
Results Reference
result

Learn more about this trial

Effect of a Modified Oxygen Mask Associated to Nasal Prongs During a High Flow Oxygenation Method

We'll reach out to this number within 24 hrs